Showing 8,121 - 8,140 results of 8,230 for search 'optimal detection (method OR methods)', query time: 0.26s Refine Results
  1. 8121

    Differential patterns of the relationship between exercise dose and mortality risk across severities of airflow limitation: a prospective cohort study with a 5-year follow-up perio... by Yide Wang, Hongxia Duan, Yingqi Wang, Yidie Bao, Linhong Jiang, Xiaoyu Han, Fengsen Li, Peijun Li, Weibing Wu, Xiaodan Liu

    Published 2025-06-01
    “…Subjects/Patients: A total of 2,975 individuals from a cohort categorized by airflow limitation severity (normal, GOLD 1–4). Methods: PA levels were quantified in metabolic equivalent hours per week (MET·h/week). …”
    Get full text
    Article
  2. 8122
  3. 8123

    Multicenter study on long-term growth in patients with phenylketonuria by S. Stanescu, A. Belanger-Quintana, J. C. Rocha, M. F. Almeida, K. Ahring, K. Dokoupil, A. M. Lammardo, E. van Dam, A. Muriel, A. MacDonald, on behalf of the ENEP group

    Published 2025-08-01
    “…The aim of this study is to determine whether the patients with PKU have a normal growth, the incidence of obesity and the relationship of these parameters with diet and nutritional intake. Material and methods This is a retrospective, multicenter, multinational study including patients with PKU from 8 centers from different countries. …”
    Get full text
    Article
  4. 8124

    Viral etiology of severe acute respiratory infections in hospitalized patients, Shandong, China. by Chunwang Li, Yujie He, Xiao Pan, Huimin Yin, Yaowen Pei, Shaoxia Song, Lin Sun, Shu Zhang, Julong Wu, Zhong Li, Xianjun Wang, Zengqiang Kou, Lei Zhao, Weijia Xing, Ti Liu

    Published 2025-01-01
    “…This study systematically characterizes the epidemiological and clinical phenotypes of SARI patients in Shouguang county, Shandong Province, China.<h4>Methods</h4>A prospective observational study was conducted at Shouguang People's Hospital between August 28, 2023 and April 30, 2024, enrolling 1,730 hospitalized patients with SARI from the Departments of Infectious Diseases and Respiratory and Critical Care Medicine. …”
    Get full text
    Article
  5. 8125

    Research progress on treatment of pleural effusion related to immune checkpoint inhibitors by AN Tianqi, TIAN Jianhui, ZHOU Yiyang, LUO Bin, QUE Zujun, LIU Yao, YU Pan, ZHAO Ruihua, YANG Yun

    Published 2025-03-01
    “…Preventing the occurrence of ICIs treatment-related pleural effusion is equally crucial, necessitating comprehensive patient assessment before ICIs administration and continuous monitoring during treatment to promptly detect and manage potential adverse reactions. Through this comprehensive management approach, the impact of ICIs treatment-related pleural effusion on patient quality of life and treatment outcomes can be minimized, optimizing overall treatment results. …”
    Get full text
    Article
  6. 8126

    Qualitative changes in clinical records after implementation of pharmacist-led antimicrobial stewardship program: a text mining analysis by Keisuke Sawada, Shuji Kono, Ryo Inose, Yuichi Muraki

    Published 2025-04-01
    “…Abstract Background Antimicrobial stewardship programs (ASPs) are essential for optimizing antimicrobial use, but many medium-sized hospitals lack infectious disease (ID) specialists. …”
    Get full text
    Article
  7. 8127

    B cell-extrinsic and intrinsic factors linked to early immune repletion after anti-CD20 therapy in patients with multiple sclerosis of African ancestry by Gregg J. Silverman, Abhimanyu N. Amarnani, Arnaldo A. Arbini, Angie Kim, Hannah Kopinsky, David Fenyo, Ilya Kister

    Published 2025-06-01
    “…In this study, we explored the immunologic and genetic factors, with serum drug monitoring, that may contribute to a faster rate of B-cell repletion that follows during recovery from treatment with anti-CD20 antibody.MethodsIn AA MS patients treated with an anti-CD20 antibody that had early repopulation of peripheral blood B cells, we assessed for extrinsic factors, including the presence of anti-drug antibodies against ocrelizumab, which may contribute to early repletion. …”
    Get full text
    Article
  8. 8128

    Machine learning applications in the analysis of sedentary behavior and associated health risks by Ayat S Hammad, Ayat S Hammad, Ali Tajammul, Ismail Dergaa, Ismail Dergaa, Ismail Dergaa, Maha Al-Asmakh, Maha Al-Asmakh

    Published 2025-06-01
    “…ML offers powerful tools for analyzing large datasets and identifying trends in physical activity and inactivity, generating insights that can support effective interventions.ObjectivesThis review aims to: (i) examine the role of ML in analyzing sedentary patterns, (ii) explore how different ML techniques can be optimized to improve the accuracy of predicting sedentary behavior, and (iii) assess strategies to enhance the effectiveness of ML algorithms.MethodsA comprehensive search was conducted in PubMed and Scopus, targeting peer-reviewed articles published between 2004 and 2024. …”
    Get full text
    Article
  9. 8129

    Juvenile dermatomyositis in Oman: clinical patterns and disease trajectory from a National cohort by Reem Abdwani, Mahadev J. Mal, Eman Al Masroori, Ruqaiya Al Jashmi, Safiya Al Abrawi, Ibrahim Al-Zakwani

    Published 2025-07-01
    “…This study aims to characterize JDM from an Omani national cohort, evaluating clinical manifestations, laboratory features, disease course, and treatment outcomes. Methods A retrospective review of all JDM patients diagnosed and managed by pediatric rheumatologist in tertiary centers in Oman was conducted. …”
    Get full text
    Article
  10. 8130

    FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) by S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova

    Published 2018-05-01
    “…To assess five-year trend in terms of specialists’ adherence to guidelines on secondary prevention of cardiovascular diseases in patients with stable angina on the level of out-patient specialized healthcare institution in Moscow.Material and methods. Two-stage retrospective pharmacoepidemiological study was conducted. …”
    Get full text
    Article
  11. 8131

    Process standardization and characterization of Mies: Ethiopian honey wine by Weleba Muesho Gebremichael, Kiros Hagos Abay, Desta Berhe Sbhatu, Goitom Gebreyohannes Berhe, Gebreselema Gebreyohannes

    Published 2024-10-01
    “…The filtrate (Mies) was seasoned and fermented for an additional two days, after which its physicochemical, nutritional, sensory, and microbial properties were analyzed using standard methods. As fermentation time increased, the pH values of the three Mies formulations decreased from the first to the twenty-first day. …”
    Get full text
    Article
  12. 8132

    Decoding chemical interactions among pomegranate, Aphis punicae, and associated insects in Taif fields through open-loop stripping by Nour Houda M’sakni, Taghreed Alsufyani, Noura J. Alotaibi

    Published 2025-06-01
    “…These VOCs are hypothesized to function as early biochemical markers of pest stress and semiochemical cues guiding insect behavior, offering potential integration into decision-support tools within integrated pest management (IPM) frameworks. MethodsVOCs were non-destructively collected using open-loop stripping and analyzed via gas chromatography–mass spectrometry under a metabolomics approach. …”
    Get full text
    Article
  13. 8133

    The Effects of the Biceps Brachii and Brachioradialis on Elbow Flexor Muscle Strength and Spasticity in Stroke Patients by Binbin Yu, Xintong Zhang, Yihui Cheng, Lingling Liu, null YanJiang, Jiayue Wang, Xiao Lu

    Published 2022-01-01
    “…We aimed to analyze the surface electromyography (sEMG) signal features of elbow flexor muscle (biceps brachii and brachioradialis) spasticity in maximum voluntary isometric contraction (MVIC) and fast passive extension (FPE) in stroke patients and to explore the main muscle groups that affect the active movement and spasticity of the elbow flexor muscles to provide an objective reference for optimizing stroke rehabilitation. Methods. Fifteen patients with elbow flexor spasticity after stroke were enrolled in this study. sEMG signals of the paretic and nonparetic elbow flexor muscles (biceps and brachioradialis) were detected during MVIC and FPE, and root mean square (RMS) values were calculated. …”
    Get full text
    Article
  14. 8134

    Potential and limitations of secondary prevention of noncommunicable diseases: data from a survey of Russian outpatient physicians by M. N. Mamedov, V. A. Kutsenko, О. M. Drapkina

    Published 2024-09-01
    “…To identify potential and limitations of secondary prevention of noncommunicable diseases in outpatient clinics of various Russian cities.Material and methods. Outpatient physicians from 16 Russian cities took part in the cross-sectional study. …”
    Get full text
    Article
  15. 8135

    A novel dual embedding few-shot learning approach for classifying bone loss using orthopantomogram radiographic notes by Pradeep Kumar Yadalam, Amit Rajabhau Pawar, Prabhu Manickam Natarajan, Carlos M. Ardila

    Published 2025-07-01
    “…This study will classify bone loss severity (normal, mild, or severe) from OPG notes using a novel dual-embedding few-shot learning framework. Methods This study used a dataset of radiographic notes from OPGs gathered at Saveetha Dental College and Hospital in Chennai. …”
    Get full text
    Article
  16. 8136

    Moss-derived human complement factor H modulates retinal immune response and attenuates retinal degeneration by Mandy Hector, Verena Behnke, Paulina Dabrowska-Schlepp, Andreas Busch, Andreas Schaaf, Thomas Langmann, Anne Wolf

    Published 2025-04-01
    “…In addition, glycans of the CPV-104 variant are sialylated, an optimization that makes CPV-104 an analog of human CFH. …”
    Get full text
    Article
  17. 8137

    Measuring protective efficacy and quantifying the impact of drug resistance: A novel malaria chemoprevention trial design and methodology. by Andria Mousa, Gina Cuomo-Dannenburg, Hayley A Thompson, R Matthew Chico, Khalid B Beshir, Colin J Sutherland, David Schellenberg, Roly Gosling, Michael Alifrangis, Emma Filtenborg Hocke, Helle Hansson, Ana Chopo-Pizarro, Wilfred F Mbacham, Innocent M Ali, Mike Chaponda, Cally Roper, Lucy C Okell

    Published 2024-05-01
    “…Here, we apply a novel modelling approach to aid the design and analysis of chemoprevention trials and generate measures of protection that can be applied across a range of transmission settings.<h4>Methods and findings</h4>We developed a model of genotype-specific drug protection, which accounts for underlying risk of infection and circulating genotypes. …”
    Get full text
    Article
  18. 8138

    Anorexia-cachexia syndrome in cancer patients: pathogenetic aspects and treatment options by A. V. Snegovoy, V. B. Larionova, I. V. Kononenko

    Published 2020-12-01
    “…First, it will allow optimizing monitoring of cancer patients predisposed to CACS development during anticancer treatment. …”
    Get full text
    Article
  19. 8139

    Plea for routine endoscopic tracheostomy tube adjustment by Bettina Otto, Regina Lindemann, Holger Kirsch, Matthias Schmid, Hartmut Vatter, Christiane Braun

    Published 2025-07-01
    “…Our data further suggest that the supply with tracheostomy tubes needs to be optimized.…”
    Get full text
    Article
  20. 8140

    Clinical safety and pharmacokinetics of a novel oral niclosamide formulation compared with marketed niclosamide chewing tablets in healthy volunteers: A three-part randomized, doub... by Niklas Walther, Robert Schultz-Heienbrok, Heino Staß, Victor M Corman, Nils C Gassen, Marcel A Müller, Christian Drosten, Martin Witzenrath, Hweeling Lee, Maximilian G Posch

    Published 2025-01-01
    “…(ClinicalTrials.gov: NCT04644705).<h4>Methods</h4>The study consisted of three parts: Part A was a double-blind placebo-controlled single ascending dose trial in three dose groups (200, 600, and 1600 mg) with four participants receiving either the investigational niclosamide formulation or placebo (3:1) under fasted and/or fed conditions. …”
    Get full text
    Article